What You Should Know
Life science infrastructure startup Cypher AI has emerged from stealth, announcing a $2M seed funding round led by MaC Venture Capital.The financing includes strategic participation from Epsilon Ventures, Connecticut Innovations, Sparta Group, and LiquidMetal Ventures.Founded in 2025 by former scientist and engineer Yaoyu Yang, PhD, the platform replaces fragmented spreadsheets, disconnected Electronic Lab Notebooks (ELNs), and legacy Laboratory Information Management
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
b.well Connected Health Partners with myTomorrows to Launch AI-Driven Clinical Trial Matching Stack
What You Should Know
Consumer health data platform b.well Connected Health has announced a strategic partnership with global health tech leader myTomorrows to automate and accelerate how patients are matched and enrolled into clinical trials.The collaboration combines b.well’s extensive, FHIR-based data network—which integrates longitudinal records from nearly 2.4 million providers, 330 health plans, and multiple state health information exchanges (HIEs)—with myTomorrows’ AI-powered clinical
Read More
Century Health Raises $5M for CHARM AI Platform to Accelerate Life Sciences Research
What You Should Know
Century Health has closed an oversubscribed $5M seed financing round led by Origin Ventures, bringing its total funding to an industry-accelerated position.The platform's proprietary Century Health Abstraction & Retrieval Model (CHARM) automates the curation of unstructured EHR data (notes, reports, and documentation), achieving a 97% accuracy rate validated against clinical expert judgment.Century Health expanded its specialty provider data network 60x over the past
Read More
Parexel Launches ParexelAI Suite of Human-Led AI Services for Clinical Trials
What You Should Know
Parexel has introduced ParexelAI™, a proprietary suite of human-led AI services designed to accelerate clinical development operations.Quantified Efficiencies: The suite is already delivering a 50% reduction in site selection timelines, a 30% reduction in medical writing for Clinical Study Reports, and a 20% reduction in safety literature screening.Regulatory Acceleration: Through a strategic partnership with Weave Bio, Parexel is reducing Investigational New Drug (IND)
Read More
Roche Acquires PathAI to Automate Cancer Diagnostics in $1B Deal
What You Should Know
Global healthcare leader Roche has entered into a definitive merger agreement to acquire US-based digital pathology pioneer PathAI for an upfront purchase price of $750M, with up to $300M in additional milestone payments.The acquisition marks the culmination of a deep strategic partnership first established between the two companies in 2021 and expanded in 2024 to co-develop AI-enabled companion diagnostic algorithms.PathAI’s flagship AISight Image Management System (IMS)
Read More
Axoft Secures $55M for Implantable Brain-Computer Interfaces and Fleuron™ Material Global Trials
What You Should Know
Axoft has raised an oversubscribed $55M Series A led by C.P. Group Innovation, bringing its total funding to over $60M.The capital will be used to expand global clinical trials, progress U.S. regulatory approval for its implantable Brain-Computer Interfaces (iBCIs), and build a GMP manufacturing facility in Cambridge, MA.Axoft’s iBCIs utilize a proprietary material called Fleuron™, which is 10,000x softer than traditional polyimide, significantly reducing tissue scarring
Read More
CareDx to Acquire Naveris for $160M to Expand into HPV-Driven Cancer MRD Monitoring
What You Should Know
CareDx has entered into a definitive agreement to acquire Naveris, a precision oncology company specializing in blood-based monitoring for viral-mediated cancers.The deal includes $160M in up-front cash, with potential for an additional $100M based on future revenue milestones.Naveris’ flagship platform utilizes Tumor Tissue Modified Viral (TTMV®) DNA to detect and monitor HPV-driven cancers with high accuracy.The acquisition is expected to close in the third quarter of
Read More
Weave Bio Launches AI-Native NDA Submission Support in Strategic Partnership with Parexel
What You Should Know
Weave Bio has expanded its AI-native regulatory platform to support New Drug Application (NDA) submissions, covering the full drug development lifecycle.Strategic partner Parexel co-developed and refined the platform, resulting in authoring speeds that are 60% faster than traditional manual methods.The platform utilizes AI-native data extraction, content verification, and automated authoring to synthesize clinical, non-clinical, and manufacturing data.Parexel will
Read More
Moderna Deploys Salesforce Agentforce Life Sciences to Unify Global Commercial Operations
What You Should Know
Moderna has selected Salesforce’s Agentforce Life Sciences to serve as its unified, global platform for commercial operations and customer engagement.The platform will consolidate data from SAP, ecommerce, and regional systems to create a single "Customer 360" source of truth for all healthcare provider (HCP) interactions.Field teams will utilize AI-powered agents to automate cycle planning, deliver "next best action" recommendations, and streamline real-time call
Read More
FDA Announces Real-Time Clinical Trial Pilot Program and Proof-of-Concept Studies with AstraZeneca and Amgen
What You Should Know
The FDA has launched two proof-of-concept (PoC) real-time clinical trials (RTCT) that report endpoints and data signals to the agency as they occur.AstraZeneca is leading a Phase 2 trial (TRAVERSE) for mantle cell lymphoma, while Amgen is conducting a Phase 1b trial (STREAM-SCLC) for small cell lung carcinoma.The initiative aims to eliminate the traditional "hiatus" between clinical phases, moving toward a model of "continuous" trials that reduces regulatory lag.A Request
Read More
